Preliminary scientific studies indicate conolidine could inhibit certain ion channels, decreasing neuronal excitability and restricting soreness signals. This mechanism is especially related in neuropathic agony, wherever irregular signaling leads to persistent soreness. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort notion.... https://johnu581xup0.jts-blog.com/profile